MADRIGAL PHARMACEUTICALS, INC. Secured Long-term Debt, Noncurrent
MADRIGAL PHARMACEUTICALS, INC. (MDGL) had Secured Long-term Debt, Noncurrent of $10.00 thousand as of 2015-06-30, per its 10-Q filed 2015-08-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:SecuredLongTermDebt · last filed 2016-03-15
- 2015-06-30: Secured Long-term Debt, Noncurrent $10.00K.
- 2015-03-31: Secured Long-term Debt, Noncurrent $2.30M.
- 2014-12-31: Secured Long-term Debt, Noncurrent $4.61M.
- 2014-09-30: Secured Long-term Debt, Noncurrent $6.91M.
| Period end | Secured Long-term Debt, Noncurrent |
|---|---|
| 2015-06-30 | $10.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $2.30M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $4.61M 10-K · filed 2016-03-15 |
| 2014-09-30 | $6.91M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $9.22M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $11.52M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $13.82M 10-K · filed 2015-03-12 |
| 2013-09-30 | $16.12M 10-Q · filed 2013-11-04 |
| 2013-06-30 | $18.42M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $20.55M 10-Q · filed 2013-04-30 |
| 2012-12-31 | $4.46M 10-K · filed 2014-03-11 |
| 2012-09-30 | $6.45M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $8.44M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $10.42M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $12.39M 10-K · filed 2013-03-14 |
| 2011-09-30 | $12.15M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $13.81M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $11.67M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |